Trial · NCT06207344
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to open eyes after anesthetics withdrawal | From time of anesthetic withdrawal to the first time of the patient open his or her eyes, assessed up to 2 hour. | The first time to open eyes after anesthetics withdrawal. |
| Secondary | Incidence of delirium | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | The Richmond Agitation-Sedation Scale (RASS) will be used to assess the incidence of delirium. RASS is a 10-point scale, with four levels of anxiety or agitation (+1 to +4 \[combative\]), one level to denote a calm and alert state (0), and 5 levels of sedation (-1 to -5) culminating in unarousable (-5). The scores of +2, +3, and +4 are defined as delirium. |
| Secondary | Incidence of nausea and vomiting | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | The severity of nausea and vomiting will be evaluated by visual analogue scale (VAS): a 10 cm ruler was used as a scale, one end (0 points) indicated no nausea and vomiting, and the other end was 10 cm, indicating the most severe nausea and vomiting that was unbearable (1\~4 was mild, 5\~6 was moderate, and 7\~10 was severe). |
| Secondary | Pain level | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | Numeric Rating Scale will be used to assess the degree of pain. 0\~10 is used to represent different degrees of pain: 0 is no pain, 1\~3 is mild pain (the pain does not affect sleep), 4\~6 is moderate pain (mildly affects sleep), 7\~9 is severe pain (unable to fall asleep or wakes up from sleep), and 10 is severe pain. |
| Secondary | Incidences of other side effects | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | Any unquestioned side effects will be recorded, such non-planned intensive care unit transfer, unplanned reoperation, unplanned reintubation, etc. |
| Secondary | Drugs and their dosage | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | These drugs and their dosage will be recorded, such as muscle relaxant antagonism, antiemetic drugs, and analgesic drugs. |
| Secondary | QoR-40 scores | Postoperative day 1 and 3. | QoR-40 scores will be used to assess the quality of recovery. The questionnaire consists of five subscales: emotional status (9 items), physical comfort (12 items), psychological support (7 items), physical independence (5 items), and pain (7 items). All the items are rated on a five-point scale ranging from 1 to 5. The initial point and conversion score of each item are calculated. Depending on the question, the best answers may have a score of either 5 or 1. The best answers to positive questions are scored 5, while the best answers to negative questions are assigned the score of 1. The total score of QoR-40 is given by the summation of scores for all items and ranges from 40 to 200. The higher the score, the better is the health status.Citation |
| Secondary | Postoperative pulmonary complications | First 7 postoperative days | The incidence of postoperative pulmonary complications was assessed according to the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) definition. The severity of postoperative pulmonary complications was scored on a 0-5 scale. |
| Secondary | White blood cell count | Postoperative day 1 and 3. | White blood cell count will be used to assess the inflammatory level. |
| Secondary | Neutrophil ratio | Postoperative day 1 and 3. | Neutrophil ratio will be used to assess the inflammatory level. |
| Secondary | Lymphocyte ratio | Postoperative day 1 and 3. | Lymphocyte ratio will be used to assess the inflammatory level. |
| Secondary | C-reactive protein | Postoperative day 1 and 3. | C-reactive protein will be used to assess the inflammatory level. |
| Secondary | Time for tidal volume of spontaneous breathing over 300 ml | From time of anesthetic withdrawal to the patient tidal volume of spontaneous breathing over 300 ml, assessed up to 2 hour. | Time from anesthetics withdrawal to tidal volume of spontaneous breathing over 300 ml. |
| Secondary | Extubation time | From time of anesthetic withdrawal to the tracheal tube was extubated, assessed up to 2 hour. | Time from anesthetics withdrawal to extubation |
| Secondary | Postanesthesia care unit residence time | From time of anesthetic withdrawal to the patient leaving the postanesthesia care unit, assessed up to 2 hour. | Time of staying in postanesthesia care unit |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06207344/registered